Ironwood Pharmaceuticals (IRWD) Return on Invested Capital (2011 - 2026)

Ironwood Pharmaceuticals has disclosed Return on Invested Capital across 8 years of filings, most recently posting 0.05% for Q1 2026.

• Return on Invested Capital for Q1 2026 came in at 0.05%, up 5.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.05% (up 5.0% YoY), and the FY2025 annual result was 0.0%, up 2.0% from the prior year.
• Return on Invested Capital came in at 0.05% for Q1 2026 at Ironwood Pharmaceuticals, up from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.09% in Q3 2023 to a low of 0.32% in Q1 2024.
• The 5-year median for Return on Invested Capital is 0.0% (2025), against an average of 0.03%.
• Across the five-year window, Return on Invested Capital plunged 32 bps in 2024 and soared 32 bps in 2025, its largest moves.
• Ironwood Pharmaceuticals' Return on Invested Capital stood at 0.0% in 2022, then plunged by 48921 bps to 0.29% in 2023, then jumped by 99 bps to 0.0% in 2024, then rose by 16 bps to 0.0% in 2025, then jumped by 2204 bps to 0.05% in 2026.
• The last three Return on Invested Capital figures came in at 0.05% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.